Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
To the Editor We read with interest the meta-analysis by Indermuehle A et al1 which reported that drug-eluting balloon (DEB) appears to show great promise for instent restenosis (ISR), and could reduce the risk for major adverse cardiac events compared with plain balloon angioplasty (BA) or implantation of drug-eluting stent (DES) in the treatment of ISR. Coronary ISR, happened after coronary stent implantation, continued to be a major problem. The authors raised a critical concern assessing the effectiveness of …
Contributors SH and YC designed the study; YC and LW extracted and analysed the data; YC and SH drafted the manuscript; YC, SH and LW revised the manuscript; SH and YC submitted the manuscript.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.